title: Adenosine 5'-triphosphate infusions reduced disease activity and inflammation in a patient with active rheumatoid arthritis.
authors.forename: Martijn J L
authors.initials: MJ
authors.lastname: Bours
authors.forename: Ralph H R M
authors.initials: RH
authors.lastname: Peeters
authors.forename: Robert B M
authors.initials: RB
authors.lastname: Landewé
authors.forename: Sandra
authors.initials: S
authors.lastname: Beijer
authors.forename: Ilja C W
authors.initials: IC
authors.lastname: Arts
authors.forename: Pieter C
authors.initials: PC
authors.lastname: Dagnelie
mesh_terms: D000203:Activities of Daily Living; D000249:Adenosine Monophosphate / Q000008:administration & dosage / Q000031:analogs & derivatives*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage*; D008875:Middle Aged; D012720:Severity of Illness Index; D013873:Thionucleotides / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D013873:Thionucleotides; C014308:adenosine 5'-phosphorothioate; D000249:Adenosine Monophosphate; D008727:Methotrexate